Table 2 Previous treatments in patients achieving clinical benefit
Best response | Progression at study entry | Previous lines of chemotherapy for metastatic disease | Previous Trastuzumab-lines for metastatic disease |
|---|---|---|---|
SD ≥ 24 weeks | NO | 3 | 3 |
SD ≥ 24 weeks | NO | 4 | 1 |
SD ≥ 24 weeks | YES* | 4 | 1 |
SD ≥ 24 weeks | NO | 3 | 1 |
SD ≥ 24 weeks | YES | 4 | 1 |
SD ≥ 24 weeks | YES** | 4 | 2 |
PR | YES* | 3 | 2 |
PR | NO | 8 | 3 |
PR | NO | 2 | 1 |
PR | YES* | 5 | 2 |